Chris Nolet

Director, Revance Therapeutics, Inc.

Companies

ArriVent BioPharma, Inc.Board member Jan 25, 2024 to now¹
Jasper Therapeutics, Inc.Board member Oct 1, 2021 to now²
Revance Therapeutics, Inc.Board member Jul 18, 2019 to Feb 6, 2025³
POLARITYTE, INC.Board member Apr 6, 2020 to Jan 17, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Jasper Therapeutics, Inc. JSPR32,500 shares⁵$15.5K at $0.48Oct 12, 2022
POLARITYTE, INC.14,403 shares⁶Jan 12, 2023
Revance Therapeutics, Inc.0 shares⁷Feb 6, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 6, 2025Returned to company 15,000 shares of Revance Therapeutics, Inc.⁷
Feb 4, 2025U 28,606 shares at $3.65 of Revance Therapeutics, Inc.⁷
May 1, 2024Granted 15,000 shares of Revance Therapeutics, Inc.⁸
May 3, 2023Granted 3,534 shares of Revance Therapeutics, Inc.⁹
Jan 12, 2023Exercised options 36,497 shares of POLARITYTE, INC.⁶
Oct 12, 2022Granted 32,500 shares of Jasper Therapeutics, Inc.⁵
Oct 1, 2022Granted 50,900 shares of POLARITYTE, INC.¹⁰
May 4, 2022Granted 6,059 shares of Revance Therapeutics, Inc.¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArriVent BioPharma, Inc., Board member
2
SEC EDGARJasper Therapeutics, Inc., Board member
3
SEC EDGARRevance Therapeutics, Inc., Board member
4
SEC EDGARPOLARITYTE, INC., Board member
5
SEC EDGARJasper Therapeutics, Inc. shares after the filing of Oct 12, 2022
6
SEC EDGARPOLARITYTE, INC. shares after the filing of Jan 12, 2023
7
SEC EDGARRevance Therapeutics, Inc. shares after the filing of Feb 6, 2025
8
SEC EDGARForm 4 filed May 3, 2024
9
SEC EDGARForm 4 filed May 5, 2023
10
SEC EDGARForm 4 filed Oct 4, 2022
11
SEC EDGARForm 4 filed May 6, 2022